Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (4072)	4/16/1998 12:24:00 PM
From: Steve Fancy	Read Replies (2) of 6136

(edited)Margie, I agree with your statement, but also believe this is about all that will hold the company up until they get something else on the market. I think you put way to much emphasis on options expiration...this is not INTC or MSFT and the stock is not part of any index that I'm aware of. A sign that options expiration was a strong influence IMO is not where the stock closes on expiration day. If the stock moves significantly in one direction before expiration, then reverses course sharply the day or two after expiration with no news then it was likely being manipulated. The bottom line right now, is a one drug company with increasing competition, who seems to know very little about where their sales are coming from in a market that's likely to correct anytime. The stock may see twenties again before it sees 40. As you know, I own a reasonable amount of this stock, not to mention options and I have no reason to bad mouth the company. I personally am very disappointed, and like to think I talk the way I feel, not my stock positions. If wish I had listened to the insider selling. These guys were not selling token amounts to cover their children's college tuition. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next